ARQT logo

ARQT
Arcutis Biotherapeutics Inc

2,466
Mkt Cap
$2.78B
Volume
611,302.00
52W High
$31.77
52W Low
$11.86
PE Ratio
-159.97
ARQT Fundamentals
Price
$22.38
Prev Close
$22.74
Open
$22.52
50D MA
$25.24
Beta
1.39
Avg. Volume
1.41M
EPS (Annual)
-$0.1269
P/B
14.57
Rev/Employee
$1.06M
$3,587.81
Loading...
Loading...
News
all
press releases
Silverleafe Capital Partners LLC Increases Stock Holdings in Arcutis Biotherapeutics, Inc. $ARQT
Silverleafe Capital Partners LLC increased its position in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT - Free Report) by 278.8% in the fourth quarter, according to its most recent disclosure with the...
MarketBeat·20h ago
News Placeholder
More News
News Placeholder
Ally Bridge Group NY LLC Invests $4.40 Million in Arcutis Biotherapeutics, Inc. $ARQT
Ally Bridge Group NY LLC bought a new position in shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with...
MarketBeat·12d ago
News Placeholder
GW&K Investment Management LLC Sells 206,391 Shares of Arcutis Biotherapeutics, Inc. $ARQT
GW&K Investment Management LLC decreased its holdings in shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT - Free Report) by 15.0% during the third quarter, according to its most recent filing...
MarketBeat·21d ago
News Placeholder
Arcutis Biotherapeutics (NASDAQ:ARQT) CFO Latha Vairavan Sells 2,853 Shares
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT - Get Free Report) CFO Latha Vairavan sold 2,853 shares of the company's stock in a transaction dated Monday, March 2nd. The shares were sold at an average...
MarketBeat·23d ago
News Placeholder
Arcutis Biotherapeutics (NASDAQ:ARQT) Insider Sells 3,687 Shares
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT - Get Free Report) insider Larry Todd Edwards sold 3,687 shares of Arcutis Biotherapeutics stock in a transaction dated Monday, March 2nd. The shares were...
MarketBeat·23d ago
News Placeholder
Masaru Matsuda Sells 3,325 Shares of Arcutis Biotherapeutics (NASDAQ:ARQT) Stock
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT - Get Free Report) insider Masaru Matsuda sold 3,325 shares of the firm's stock in a transaction that occurred on Friday, February 27th. The stock was sold...
MarketBeat·23d ago
News Placeholder
Patrick Burnett Sells 6,287 Shares of Arcutis Biotherapeutics (NASDAQ:ARQT) Stock
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT - Get Free Report) insider Patrick Burnett sold 6,287 shares of the stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an...
MarketBeat·23d ago
News Placeholder
Masaru Matsuda Sells 8,733 Shares of Arcutis Biotherapeutics (NASDAQ:ARQT) Stock
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT - Get Free Report) insider Masaru Matsuda sold 8,733 shares of the firm's stock in a transaction that occurred on Monday, March 2nd. The stock was sold at...
MarketBeat·23d ago
News Placeholder
Insider Selling: Arcutis Biotherapeutics (NASDAQ:ARQT) Insider Sells 37,349 Shares of Stock
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT - Get Free Report) insider Todd Watanabe sold 37,349 shares of the stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an...
MarketBeat·23d ago
News Placeholder
Arcutis Biotherapeutics (NASDAQ:ARQT) Stock Price Down 6.9% After Analyst Downgrade
Arcutis Biotherapeutics (NASDAQ:ARQT) Stock Price Down 6.9% on Analyst Downgrade...
MarketBeat·25d ago
<
1
2
...
>

Latest ARQT News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.